Literature DB >> 1324196

The role of the C-terminal region of rat brain natriuretic peptide in receptor selectivity.

Y Shimekake1, T Kawabata, M Nakamura, K Nagata.   

Abstract

Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) have different C-terminal tail structures compared with the rather conservative ring structures which consist of 17 amino acid residues. To examine the different effects of the tail structures of ANP and BNP on their interaction with receptors, we synthesized several peptide analogs and measured their biological actions in three different assay systems. Deletion of the C-terminal tail from rat BNP did not effect the vasorelaxation activity against rat aorta, but it promoted cGMP production in cultured rat aortic smooth muscle cells (RASMC). Deletion of the C-terminal tail from rat ANP diminished both vasorelaxant and cGMP producing activities. In a binding competition assay with RASMC and [125I]rat ANP-(1-28), the competition activities of both ANP and BNP were greatly reduced by C-terminal deletion. In addition, we obtained agonists with novel receptor selectivity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324196     DOI: 10.1016/0014-5793(92)81091-y

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response.

Authors:  Luis A Ralat; Qing Guo; Min Ren; Todd Funke; Deborah M Dickey; Lincoln R Potter; Wei-Jen Tang
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

2.  A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.

Authors:  Paul M McKie; Alessandro Cataliotti; Brenda K Huntley; Fernando L Martin; Timothy M Olson; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2009-09-08       Impact factor: 24.094

3.  Knockdown of Carboxypeptidase A6 in Zebrafish Larvae Reduces Response to Seizure-Inducing Drugs and Causes Changes in the Level of mRNAs Encoding Signaling Molecules.

Authors:  Mark William Lopes; Matthew R Sapio; Rodrigo B Leal; Lloyd D Fricker
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.